MSc. with 1st Class in Genetics,Human Genetics, Life Sciences, Biochemistry from recognized university and suitability bases on CSIR, UGC, ICMR, DBT, etc.
B.Pharmacy or B. Sc. and Master degree M.Pharm, M.S. Pharm or M. Sc. in Molecular Biology with minimum of 60% marks from a recognized Indian or Foreign University.
Doctoral degree in science or masters degree in engineering or technology from a recognized University in a relevant discipline. Proteomics of medically important snakes of North-east India and development of diagnostic assays for the identification of snake bite at species level
M.Pharm, M.Sc, Pharm.D candidates who completed a Diploma course in clinical research and with at least three-year experience in handling clinical trials
PhD, MD, MPH, Doctor of Pharmacy or any other equivalent Degree with minimum two years of experience in research. A minimum of three SCOPUS indexed Q1 publications in peer-reviewed journals are viewed positively.
First Class Post Graduate Degree, including the integrated PG degrees with three Years of relevant Experience or P.hD OR Second Class Post Graduate Degree, including the integrated PG degrees with PhD and three Years Experience.
First class Post Graduate Degree, including the integrated PG degrees. Research experience in Pharmaceutics, in vitro cell culture, molecular-based techniques, and animal handling. Investigating the therapeutic potential of refractory status epilepsy
First class M.Sc in Biological Sciences, Biotechnology, Pharmaceutical Sciences, Chemistry. Applicant must be qualified in any one of the following tests CSIR, UGC, ICMR including Lectureship
Good Academic record with First Class Master Degree in Chemistry, Biochemistry, Biotechnology. The Candidate should have qualified National Eligibility Test CSIR, UGC-JRF or DBT-BET Category-I and II, ICMR, DST-Inspire Fellowship